It can be prevented.

CardioPhi’s software empowers clinicians with real-time predictive analysis of the patient's cardiac activities, enabling faster diagnoses, timely interventions, and cost-effective care.

Our proud sponsors



Continuous real-time monitoring of heart rhythms through electrocardiogram (ECG) analysis, with instant feedback & alerts.


Artificial Intelligence driven predictions for proactive patient care, leveraging historical data to forecast potential cardiac events.


Timely action to prevent serious heart conditions, enable early detection & targeted intervention for improved patient outcomes.

About Us

CardioPhi, a digital health company incubated at Harvard Innovation Labs provides Artificial Intelligence solutions for the automatic and reliable interpretation of electrocardiograms (ECG) in real-time.

Our mission is to enhance patient outcomes for the millions affected by cardiac arrhythmias while simultaneously reducing public spending on cardiovascular diseases.


“There is a large clinical need for arrhythmia prediction to prevent adverse medical events such as embolic strokes as well as a significant need to reduce the burden on clinicians in terms of time saving and insights.”


Cardiac Electrophysiologist

“Prediction of atrial arrhythmias could be used to prevent tachycardia that commonly occurs as congestive heart failure and embolic stroke. Prediction of ventricular arrhythmias could most importantly be used to prevent sudden cardiac death.”


Attending Physician and
Professor of Emergency Medicine

“CardioPhi technology has the ability to revolutionize the way cardiologists approach preventative care and intervene before complications arise.”


Cardiac Electrophysiologist